Sort
82,697 grants matching “vaccine development”
Project 1 - Profectus Biosciences, Inc.
$805,740John H Eldridge · Henry M. Jackson Fdn For The Adv Mil/Med · U19 · FY2019 · AI
Lysine Acetylation in N. gonorrhoeae Quorum Sensing and Biofilm Formation
$805,715John R Kirby · University Of Iowa · R01 · FY2015 · AI
Role of Gut and Skin Flora in the Control of Immune Responses
$805,707Yasmine Belkaid · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
MOLECULAR SIGNATURES OF IMMUNE RESPONSE TO VACCINATION
$805,661Alan A Aderem · Emory University · U19 · FY2008 · AI
The Role of Lipid-specific T cells in Mediating Protection Against M. tuberculosis
$805,629Chetan Seshadri · University Of Washington · R01 · FY2022 · AI
Development of pan-betacoronavirus vaccines
$805,612Raiees Ahmad Andrabi · Scripps Research Institute, The · R01 · FY2023 · AI
Development of a Sustained Release Injectable Formulation for Long-Term Delivery of ELQs
$805,568Michael Kevin Riscoe · Oregon Health & Science University · R01 · FY2022 · AI
Skin microbiome contributions to the pathogenesis of cutaneous leishmaniasis
$805,550Phillip A. Scott · University Of Pennsylvania · R01 · FY2025 · AI
Recombinant Vaccines for Prevention of AIDS and Other Diseases
$805,377Bernard Moss · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
Understanding the Tropism and Pathogenesis of Pararubulaviruses
$805,375Benhur Lee · Icahn School Of Medicine At Mount Sinai · R37 · FY2025 · AI
ACE2-targeted PET radiotracers for investigating spatiotemporal distribution of SARS-CoV-2 organ injury and therapy response.
$805,361David M Wilson · University Of California, San Francisco · R01 · FY2023 · AI
Exploring Wolbachia for malaria control
$805,360Zhiyong Xi · Michigan State University · R01 · FY2024 · AI
Influence of maternal virome and HIV status on infant gut virome, growth and immunity
$805,358Heather Beryl Jaspan · Seattle Children'S Hospital · R01 · FY2020 · HD
Experimental Gonococcal Vaccine
$805,248Yingru Liu · Therapyx, Inc. · R44 · FY2017 · AI
CRYPTOCOCCUS NEOFORMANS--A MODEL FOR PATHOGENIC FUNGI
$805,235Duke University · P01 · FY2001 · AI
Antiviral agents directed to novel targets in the adenovirus proteinase
$805,153Walter F. Mangel · Brookhaven Science Assoc-Brookhaven Lab · R01 · FY2008 · AI
Real-World Effectiveness of Perinatal RSV Immunoprophylaxis
$805,130Carlos Rafael Oliveira · Yale University · R01 · FY2025 · AI
Southern California Primary Infection Program
$805,095University Of California San Diego · U01 · FY2003 · AI
Characterization of CAR-directed T-cells to suppress HIV-1 in vivo
$805,040Scott G Kitchen · University Of California Los Angeles · U19 · FY2015 · AI
Social Determinants of the Autism Epidemic
$805,000Peter Shawn Bearman · Columbia Univ New York Morningside · DP1 · FY2007 · OD
Social Determinants of the Autism Epidemic
$805,000Peter Shawn Bearman · Columbia Univ New York Morningside · DP1 · FY2008 · OD
Social Determinants of the Autism Epidemic
$805,000Peter Shawn Bearman · Columbia Univ New York Morningside · DP1 · FY2009 · OD
Viral and Host Dynamics during Pediatric COVID-19 and Respiratory Virus Co-Infection
$804,976Judd F Hultquist · Northwestern University At Chicago · R01 · FY2024 · AI
Signal Transduction In B Lymphocytes: Identification Of Key Signaling Molecules
$804,943John H Kehrl · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
Molecular and structural characterization of broadly neutralizing anti-HCV antibodies
$804,923Justin Richard Bailey · Johns Hopkins University · R01 · FY2024 · AI